mTOR Inhibitor Immunosuppressant [EPC]

59815 reported adverse events

Drugs of this class: SIROLIMUS EVEROLIMUS EVEROLIMUS TABLETS

These side effects are most commonly reported by patients taking drugs of the mTOR Inhibitor Immunosuppressant [EPC] class:

# Side effect Count
0 DEATH 6516
1 DIARRHOEA 4278
2 MALIGNANT NEOPLASM PROGRESSION 4172
3 FATIGUE 3761
4 STOMATITIS 3134
5 OFF LABEL USE 3022
6 NAUSEA 2862
7 DYSPNOEA 2778
8 DRUG INEFFECTIVE 2685
9 PYREXIA 2653
See all common reactions for mTOR Inhibitor Immunosuppressant [EPC]

Drugs of the mTOR Inhibitor Immunosuppressant [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 79 0.4438
1 TRANSPLANT DYSFUNCTION 491 0.3540
2 PIK3CA-ACTIVATED MUTATION 65 0.2731
3 PANCREATIC NEUROENDOCRINE TUMOUR 125 0.2648
4 POLYOMAVIRUS VIRAEMIA 107 0.2296
5 SMOOTH MUSCLE CELL NEOPLASM 51 0.2189
6 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 38 0.2099
7 NEUROENDOCRINE TUMOUR 216 0.1951
8 LYMPHOCELE 116 0.1883
9 TRANSPLANT REJECTION 1031 0.1690
See all enriched reactions for mTOR Inhibitor Immunosuppressant [EPC]